Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
For sure a brick wall @ 3ish!!
31,200 sold
Balance :2,282,159
By
Opaleye
05/21/2024
1,800 sold @ $3.0557
124,250
Manage account (2)
05/22/2024
9,300 sold @ $3.021
2,272,859 : balance
Very surprised seeing they are typically long term holders, and the future seems bright…perhaps they are reallocating to other losers they have (RVNC for one)
This is a $25+ PP prob in 2025…oh well, less overhead , some fund is buying I’m sure( prob the groups from recent offering) GLTA
Opaleye keeps blowing out blocks a touch above $3 for whatever reason!!! Overhang a hinderance until their done selling..hopefully tomorrow at Cowan conf Jesse says some magic words concerning IV Choline Clor/FDA
Protara Therapeutics to Present at the TD Cowen 5th Annual Oncology Innovation Summit
May 21, 2024
Download PDF
NEW YORK, May 21, 2024 (GLOBE NEWSWIRE) --Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that management will participate in a virtual fireside chat at the TD Cowen 5th Annual
Oncology Innovation Summit on Tuesday, May 28,
2024 at 3:00 pm ET.
I believe this is for Ken Griffins own account
https://ir.protaratx.com/static-files/2cffa79d-9e22-4a12-a866-5308e96d8bad
--Oppenheimer Adjusts Protara
Therapeutics Price Target to $30
From $26
MT Newswires 08:44AM ET, 04/22/2024
Almost 100% increase in share count( major dilution) …Market Cap pre offering ~$46mm and Post equals ~$75mm( todays price)…yes, better balance sheet, positive interim data..all in all good news, but Arbs will mess around for a bit until Funds buy again…
Jesse is pretty good steward of capital, so when q1 is reported we will see what intrinsic value is ..GLTA
sometimes have to read btw the lines*****biotech*****trial,clinical trials will taketimeand money. longtimeinvestment mosttimes
Why would it go red even with all the good news??
Protara Therapeutics Announces Oversubscribed $45 Million Private Placement Financing
I know Monk, this should hit 5 before data. On another note ANV*S had their 10K today.
Agreed everything in due time with TARA
Only a few months left for the data to be released.
I guess, I live in your head rent free now stupid peasant. Listen I just had lovely dinner and about to take a crap, going to think of you while I am taking a crap, with your mouth full open while I take a crap in it. Send whatever you want to the SEC, lets see what you got, you think they will listen to a peasant like you?
Send the SEC your posts and your sell tickets so they can match them up.. pump and dump artist..
Save them all dumb peasant. I helped the SEC nail Alex Delarge you peasant.
Ok saving your post for the SEC. Thanks dummy
This is going to hit the teens after the data read out moron. Furthermore this is a nasdaq stock not the scams you are accustomed to peasant.
Beware folks.. there are pumpers with price predictions on here looking to close positions as they pump.. just my opinion but I think it's true.. any posts by predictors are suspect.. they are likely looking to sell..
TARA 5 to 6 dollars before data readout.
TARA 5-6 before data release, then once the data is confirmed easy will see the teens.
I been adding all the way down I like the potential here on this one fingers crossed
Hey bud, I don't have subscription anymore and refuse to pay, don't need it anymore. You got to stick out with this one and add when and if you can, news pending and they investor conference tomorrow.
Yup buying opportunities await
Wait couple of more days to add.
TARA has done exceptionally well. Only a matter of time.
Sounds good in it here 4 future growth
Data comes out positive look out above pound. Baker Brother still in the game and that is all we need to know.
Looks good Dino thanks 4 posting alert
Great action here pound. Should hit 5-6 before news.
They probably left last year, like you said for tax harvesting, it does look like it though, the stock bottoming in the low 1.05 range, which killed the stock, but it is coming back after it bottomed. Simple logic tells me, they have 300 million dollar shelf offering right now in the pipe line and there is no way they can do it here, so I think they have colluded with the market makers to drive the price higher, 5-6 dollars before news or even higher, no one knows their trick except for themselves, it would not make sense to sell securities in this range when the volume is anemic. Take a look at MDG*L chart, started at 5 range and shot up to 300-400 dollars in less than week, that one also has Baker Brothers in it and I believe it is also bladder and Liver cancer issues. Bottom line, if these ticker has the science, it will do wonders. 4 billion market cap vs 40 million market cap, so I say easily by June we can get to double digits.
Maybe Just year end for tax harvesting ( if they can even benefit ) or YE portfolio shuffling….they were probably leaning it all the way down to $1.5 where I picked up a bunch ( sold some too early last week @ $3.55 ( can’t argue with taken a profit) …still my largest position and will hold until we get double digits ! Jesse was at those 2 conferences, plus the Bakers ( like you said, and totally agree) helps…
Data readouts coming soon ( prob by May)
Looks like they sold. Orbimed is not as important as Baker Brothers to me, but I am curious though why Orbimed sold, we won't know until the results come out.
OrbiMed filed 13g/a but can’t tell if they added or sold??
TARA moving nicely, should be around $5.00 before the results.
Maybe we get a bump from Conf’s:
Protara Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire 07:30AM ET, 01/31/2024
NEW YORK, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that management will participate in the following investor conferences:
• Guggenheim Healthcare Talks 6th
Annual Biotechnology Conference. A fireside chat will take place on Wednesday, February 7, 2024 at
10:30 am ET in New York.
• Oppenheimer 34th Annual Healthcare Life Sciences Conference. A fireside chat will take place virtually on Wednesday, February 14, 2024 at
8:40 am ET.
TARA.................................https://stockcharts.com/h-sc/ui?s=TARA&p=W&b=5&g=0&id=p86431144783
Orbimed and Baker Brothers is all you need to know. This will hit high double digits between March and June, maybe even sooner.
This is a good one bud, still holding and waiting on that big news.
Looking forward hopefully to seeing some 13G/A’s, insider purchases, etc…Data readouts prob early Q2, maybe even late Q1 :)
Jesse keeps cash burn low, and RSU’s are reasonable to employees!!
Intrinsic value( after cash burn end of 2023) of perhaps $3.5-4per share( fully diluted share count about 18mm*)($50mm collecting interest income )
10k & Q prob out in March , should be good reading material
*series 1 preferred 8000sh can convert
Awesome, you can't got wrong with these prices, just buy slowly, this should organically grow its wings. Bladder cancer market is huge, companies with more advance trials are worth billions. There is a reason why Baker Brothers is here, I think at some point next year they will increase their position, once this years taxes are done, it will be a great year next year for this.
Followers
|
9
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
77
|
Created
|
01/22/20
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |